Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

about

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.

P2860

Q53265540-3310D7D1-E729-4EFB-9BAC-B3C20C9F2014

P2860

Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q53110056

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@en

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@nl

type

Item

label

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@en

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@nl

prefLabel

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@en

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@nl

P1476

Normal karyotype mosaicism in ...... tic stem cell transplantation.

@en

P2093

Byung-Sik Cho

http://www.w3.org/2001/XMLSchema#string

Chang-Ki Min

http://www.w3.org/2001/XMLSchema#string

Chong-Won Park

http://www.w3.org/2001/XMLSchema#string

Dong-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Je Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Ho Yoon

http://www.w3.org/2001/XMLSchema#string

Jong-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Ki-Seong Eom

http://www.w3.org/2001/XMLSchema#string

Seok Lee

http://www.w3.org/2001/XMLSchema#string

Seok-Goo Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms and consequences of somatic mosaicism in humans

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Impact of residual normal metaphases in core binding factor acute myeloid leukemia

KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.

Karyotype and FISH analysis of a newly established cell line derived from a human bladder carcinoma.

Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype.

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome.

Autologous stem cell transplantation using modified TAM or combination of triple-alkylating agents conditioning regimens as one of the post-remission treatments in patients with adult acute myeloid leukemia in first complete remission.

Survival of children with mosaic Down syndrome.

P2888

s12185-013-1335-7

P304

773-781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-013-1335-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23616221

http://www.w3.org/2001/XMLSchema#string

P921

karyotype

Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

about

P2860

P2860

Normal karyotype mosaicism in adult AML patients with adverse-risk and undefined karyotype: preliminary report of treatment outcomes after hematopoietic stem cell transplantation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921